Potentially Inappropriate Medication and Associated Factors Among Older Patients with HIV/AIDS: A Multicenter Cross-Sectional Study.

IF 3.7 3区 医学 Q2 GERIATRICS & GERONTOLOGY
Clinical Interventions in Aging Pub Date : 2025-07-30 eCollection Date: 2025-01-01 DOI:10.2147/CIA.S519649
Jia Li, Dongsheng Hong, Jiankun Dong, Qingwei Zhao, Hongmei Wang
{"title":"Potentially Inappropriate Medication and Associated Factors Among Older Patients with HIV/AIDS: A Multicenter Cross-Sectional Study.","authors":"Jia Li, Dongsheng Hong, Jiankun Dong, Qingwei Zhao, Hongmei Wang","doi":"10.2147/CIA.S519649","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study sought to characterize the prevalence, patterns, and associated risk factors for Potentially Inappropriate Medication use among older patients living with HIV/AIDS. The ultimate goal of this study is to inform strategies to increase medication safety in this vulnerable population.</p><p><strong>Patients and methods: </strong>Using the 2023 American Geriatrics Society Beers Criteria, we performed a comprehensive retrospective analysis of medication use patterns among HIV/AIDS patients aged ≥65 years, drawing data from 21 hospitals across eight Chinese cities between 2019 and 2023. The analytical framework incorporated descriptive statistics, negative binomial regression for trend analysis, and multivariable logistic regression to evaluate PIM prevalence and identify associated risk factors.</p><p><strong>Results: </strong>The analysis included 2,642 patients (80.28% male; median age 71 years, IQR: 67~75). The PIM prevalence was 23.20% (613/2,642) in the cohort, with medications contraindicated in older adults constituting the largest category (51.87%), followed by disease-related PIMs (19.88%) and medications requiring cautious use (27.80%). Type 3 PIMs demonstrated a consistent and statistically significant downward trend throughout the study period (<i>P</i><0.001). Conversely, using a single PIM exhibited a statistically significant upward trajectory (<i>P</i>=0.020). In multivariate modeling, polypharmacy emerged as the strongest predictor of PIM use (adjusted OR=9.05, 95% CI: 7.20~11.38), followed by hospitalization (adjusted OR=1.38, 95% CI: 1.05~1.80), with consistent associations observed across the 65~84 year age range (all <i>P</i><0.05).</p><p><strong>Conclusion: </strong>The substantial and increasing burden of PIM use among elderly patients living with HIV/AIDS underscores the urgent need for enhanced medication oversight. Targeted intervention strategies should prioritize patients with polypharmacy, those requiring hospitalization, and those with specific age demographics.</p>","PeriodicalId":48841,"journal":{"name":"Clinical Interventions in Aging","volume":"20 ","pages":"1155-1164"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12318528/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Interventions in Aging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CIA.S519649","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study sought to characterize the prevalence, patterns, and associated risk factors for Potentially Inappropriate Medication use among older patients living with HIV/AIDS. The ultimate goal of this study is to inform strategies to increase medication safety in this vulnerable population.

Patients and methods: Using the 2023 American Geriatrics Society Beers Criteria, we performed a comprehensive retrospective analysis of medication use patterns among HIV/AIDS patients aged ≥65 years, drawing data from 21 hospitals across eight Chinese cities between 2019 and 2023. The analytical framework incorporated descriptive statistics, negative binomial regression for trend analysis, and multivariable logistic regression to evaluate PIM prevalence and identify associated risk factors.

Results: The analysis included 2,642 patients (80.28% male; median age 71 years, IQR: 67~75). The PIM prevalence was 23.20% (613/2,642) in the cohort, with medications contraindicated in older adults constituting the largest category (51.87%), followed by disease-related PIMs (19.88%) and medications requiring cautious use (27.80%). Type 3 PIMs demonstrated a consistent and statistically significant downward trend throughout the study period (P<0.001). Conversely, using a single PIM exhibited a statistically significant upward trajectory (P=0.020). In multivariate modeling, polypharmacy emerged as the strongest predictor of PIM use (adjusted OR=9.05, 95% CI: 7.20~11.38), followed by hospitalization (adjusted OR=1.38, 95% CI: 1.05~1.80), with consistent associations observed across the 65~84 year age range (all P<0.05).

Conclusion: The substantial and increasing burden of PIM use among elderly patients living with HIV/AIDS underscores the urgent need for enhanced medication oversight. Targeted intervention strategies should prioritize patients with polypharmacy, those requiring hospitalization, and those with specific age demographics.

老年HIV/AIDS患者的潜在不适当用药及其相关因素:一项多中心横断面研究
目的:本研究旨在描述老年艾滋病毒/艾滋病患者中潜在不适当药物使用的患病率、模式和相关危险因素。本研究的最终目的是为提高这一弱势群体的用药安全性提供信息。患者和方法:使用2023年美国老年医学会比尔斯标准,我们对2019年至2023年中国8个城市21家医院的年龄≥65岁的HIV/AIDS患者的药物使用模式进行了全面的回顾性分析。分析框架采用描述性统计、负二项回归趋势分析和多变量logistic回归来评估PIM患病率并确定相关危险因素。结果:纳入2642例患者,其中男性80.28%;中位年龄71岁,IQR: 67~75)。队列中PIM患病率为23.20%(613/ 2642),其中老年人禁忌症药物占最大类别(51.87%),其次是疾病相关PIM(19.88%)和需要谨慎使用的药物(27.80%)。3型pim在整个研究期间呈现一致且具有统计学意义的下降趋势(PP=0.020)。在多变量模型中,多种用药是PIM使用的最强预测因子(调整后的OR=9.05, 95% CI: 7.20~11.38),其次是住院(调整后的OR=1.38, 95% CI: 1.05~1.80),在65~84岁年龄组中观察到一致的关联(均为p)结论:老年艾滋病毒/艾滋病患者PIM使用的巨大和不断增加的负担强调了加强用药监督的迫切需要。有针对性的干预策略应优先考虑使用多种药物的患者、需要住院治疗的患者和具有特定年龄人口统计学特征的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Interventions in Aging
Clinical Interventions in Aging GERIATRICS & GERONTOLOGY-
CiteScore
6.80
自引率
2.80%
发文量
193
审稿时长
6-12 weeks
期刊介绍: Clinical Interventions in Aging, is an online, peer reviewed, open access journal focusing on concise rapid reporting of original research and reviews in aging. Special attention will be given to papers reporting on actual or potential clinical applications leading to improved prevention or treatment of disease or a greater understanding of pathological processes that result from maladaptive changes in the body associated with aging. This journal is directed at a wide array of scientists, engineers, pharmacists, pharmacologists and clinical specialists wishing to maintain an up to date knowledge of this exciting and emerging field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信